Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ECHSX vs. PRHSX: which is better?

Bottom line

ECHSX vs PRHSX: the short answer

ECHSX (Eaton Vance Worldwide Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.

But PRHSX is far broader, holding 279 positions to 42 for ECHSX, so beyond the top names it adds exposure ECHSX doesn't have.

PRHSX is cheaper at 0.83% vs 1.93% — a difference of $110 a year per $10,000 invested.

Over five years, ECHSX returned +5.6% a year vs +4.2% for PRHSX (reporting dates differ).

Updated Nov 19, 2026

ECHSX vs PRHSX side by side

ECHSXPRHSX
TypeMutual fundMutual fund
Fund familyMorgan StanleyT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.93%0.83%
Annual cost per $10k$193$83
10-yr cost on $10k (prospectus)$2,089$1,025
Max front load0%—
12b-1 fee1%—
1-yr return+1.7%+17.7%
5-yr return (annualized)+5.6%+4.2%
10-yr return (annualized)+6.3%+9.1%
Best quarter—+23.5%
Worst quarter—−15.8%
Net assets (fund)$757.9M$11.9B
Number of holdings42279
Portfolio turnover3%62%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

12 of ECHSX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingECHSXPRHSX
Eli Lilly & Co12.47%14.28%
AbbVie Inc6.46%5.10%
Johnson & Johnson6.45%6.63%
UnitedHealth Group Inc5.49%5.99%
Merck & Co Inc5.08%4.01%
Bristol-Myers Squibb Co4.25%2.11%
Vertex Pharmaceuticals Inc3.38%2.28%
Gilead Sciences Inc3.34%2.82%
Thermo Fisher Scientific Inc2.79%2.52%
Intuitive Surgical Inc2.72%1.87%
Stryker Corp2.21%1.78%
Abbott Laboratories1.65%1.89%

Source: SEC Form N-PORT

ECHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between ECHSX and PRHSX?
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. But PRHSX is far broader, holding 279 positions to 42 for ECHSX, so beyond the top names it adds exposure ECHSX doesn't have.
Which is cheaper, ECHSX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both ECHSX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.